More articles from Clinical Investigation

Open Access
Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma
Nathalie L. Albert, Debie V. Nelwan, Daniel F. Fleischmann, Stefanie Quach, Katharina von Rohr, Lena Kaiser, Nico Teske, Lena M. Unterrainer, Laura M. Bartos, Viktoria C. Ruf, Matthias Brendel, Markus J. Riemenschneider, Christian Wetzel, Jochen Herms, Rainer Rupprecht, Niklas Thon, Joerg-Christian Tonn, Claus Belka, Peter Bartenstein, Louisa von Baumgarten, Maximilian Niyazi, Marcus Unterrainer and Adrien Holzgreve

Journal of Nuclear Medicine August 3, 2023, jnumed.122.265247; DOI: https://doi.org/10.2967/jnumed.122.265247
You have access
Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for ⁸⁹Zr-Trastuzumab
Philipp Mohr, Joyce van Sluis, Laura Providência, Johannes H. van Snick, Marjolijn N. Lub-de Hooge, Antoon T. Willemsen, Andor W.J.M. Glaudemans, Ronald Boellaard, Adriaan A. Lammertsma, Adrienne H. Brouwers and Charalampos Tsoumpas

Journal of Nuclear Medicine August 3, 2023, jnumed.123.265621; DOI: https://doi.org/10.2967/jnumed.123.265621
Open Access
Initial Evaluation of [¹⁸F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
Tadashi Watabe, Sadahiro Naka, Mitsuaki Tatsumi, Takashi Kamiya, Toru Kimura, Yasushi Shintani, Kaori Abe, Tomohiro Miyake, Kenzo Shimazu, Shogo Kobayashi, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki, Hidenori Inohara, Hiroki Kato, Yuriko Mori, Jens Cardinale and Frederik L. Giesel

Journal of Nuclear Medicine August 1, 2023, 64 (8) 1225-1231; DOI: https://doi.org/10.2967/jnumed.123.265486
You have access
Evaluation of the Diagnostic Accuracy of FAPI PET/CT in Oncologic Studies: Systematic Review and Metaanalysis
Grayson Wass, Kari Clifford and Rathan M. Subramaniam

Journal of Nuclear Medicine August 1, 2023, 64 (8) 1218-1224; DOI: https://doi.org/10.2967/jnumed.123.265471
Open Access
Clinical Evaluation of ⁶⁸Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin α_vβ₃ in Various Cancer Types
Liang Zhao, Xuejun Wen, Weizhi Xu, Yizhen Pang, Long Sun, Xiaoming Wu, Pengfei Xu, Jingjing Zhang, Zhide Guo, Qin Lin, Xiaoyuan Chen and Haojun Chen

Journal of Nuclear Medicine August 1, 2023, 64 (8) 1210-1217; DOI: https://doi.org/10.2967/jnumed.122.265383
You have access
The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer
Marinus J. Hagens, Wietske I. Luining, Auke Jager, Maarten L. Donswijk, Zing Cheung, Maurits Wondergem, Daniela E. Oprea-Lager, André N. Vis, Pim J. van Leeuwen and Henk G. van der Poel

Journal of Nuclear Medicine August 1, 2023, 64 (8) 1238-1243; DOI: https://doi.org/10.2967/jnumed.122.265205
You have access
Evaluation of [⁶⁸Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space
Aleksandar Milosevic, Hanna Styczen, Johannes Grueneisen, Yan Li, Manuel Weber, Wolfgang P. Fendler, Julian Kirchner, Philipp Damman, Karsten Wrede, Lazaros Lazaridis, Martin Glas, Maja Guberina, Anja Eckstein, Tobias Blau, Ken Herrmann, Lale Umutlu, Michael Forsting, Cornelius Deuschl and Benedikt Schaarschmidt

Journal of Nuclear Medicine August 1, 2023, 64 (8) 1185-1190; DOI: https://doi.org/10.2967/jnumed.123.265424
You have access
[¹⁷⁷Lu]Lu-PSMA-Radioligand Therapy Efficacy Outcomes in Taxane-Naïve Versus Taxane-Treated Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Metaanalysis
Swayamjeet Satapathy, Ranjit K. Sahoo and Chandrasekhar Bal

Journal of Nuclear Medicine August 1, 2023, 64 (8) 1266-1271; DOI: https://doi.org/10.2967/jnumed.123.265414
You have access
Safety and Efficacy of [¹⁷⁷Lu]-PSMA-I&T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years
Robert Tauber, Karina Knorr, Margitta Retz, Isabel Rauscher, Sonia Grigorascu, Kimberley Hansen, Calogero D’Alessandria, Hans-Jürgen Wester, Jürgen Gschwend, Wolfgang Weber, Matthias Eiber and Thomas Langbein

Journal of Nuclear Medicine August 1, 2023, 64 (8) 1244-1251; DOI: https://doi.org/10.2967/jnumed.122.265259
Open Access
A VISION Substudy of Reader Agreement on ⁶⁸Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for ¹⁷⁷Lu-PSMA-617 Radioligand Therapy
Phillip H. Kuo, Don C. Yoo, Ryan Avery, Marc Seltzer, Jeremie Calais, James Nagarajah, Wolfgang A. Weber, Wolfgang P. Fendler, Michael S. Hofman, Bernd J. Krause, Marcia Brackman, Euloge Kpamegan, Samson Ghebremariam, Taylor Benson, Ana M. Catafau and Ayse T. Kendi

Journal of Nuclear Medicine August 1, 2023, 64 (8) 1259-1265; DOI: https://doi.org/10.2967/jnumed.122.265077

Main menu

User menu

Search

More articles from Clinical Investigation

Pages